Literature DB >> 22219181

Novel role for non-muscle myosin light chain kinase (MLCK) in hyperoxia-induced recruitment of cytoskeletal proteins, NADPH oxidase activation, and reactive oxygen species generation in lung endothelium.

Peter V Usatyuk1, Patrick A Singleton, Srikanth Pendyala, Satish K Kalari, Donghong He, Irina A Gorshkova, Sara M Camp, Jaideep Moitra, Steven M Dudek, Joe G N Garcia, Viswanathan Natarajan.   

Abstract

We recently demonstrated that hyperoxia (HO) activates lung endothelial cell NADPH oxidase and generates reactive oxygen species (ROS)/superoxide via Src-dependent tyrosine phosphorylation of p47(phox) and cortactin. Here, we demonstrate that the non-muscle ~214-kDa myosin light chain (MLC) kinase (nmMLCK) modulates the interaction between cortactin and p47(phox) that plays a role in the assembly and activation of endothelial NADPH oxidase. Overexpression of FLAG-tagged wild type MLCK in human pulmonary artery endothelial cells enhanced interaction and co-localization between cortactin and p47(phox) at the cell periphery and ROS production, whereas abrogation of MLCK using specific siRNA significantly inhibited the above. Furthermore, HO stimulated phosphorylation of MLC and recruitment of phosphorylated and non-phosphorylated cortactin, MLC, Src, and p47(phox) to caveolin-enriched microdomains (CEM), whereas silencing nmMLCK with siRNA blocked recruitment of these components to CEM and ROS generation. Exposure of nmMLCK(-/-) null mice to HO (72 h) reduced ROS production, lung inflammation, and pulmonary leak compared with control mice. These results suggest a novel role for nmMLCK in hyperoxia-induced recruitment of cytoskeletal proteins and NADPH oxidase components to CEM, ROS production, and lung injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219181      PMCID: PMC3308820          DOI: 10.1074/jbc.M111.294546

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury.

Authors:  Tamara Mirzapoiazova; Jaideep Moitra; Liliana Moreno-Vinasco; Saad Sammani; Jerry R Turner; Eddie T Chiang; Carrie Evenoski; Ting Wang; Patrick A Singleton; Yong Huang; Yves A Lussier; D Martin Watterson; Steven M Dudek; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2010-02-05       Impact factor: 6.914

2.  Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium.

Authors:  Mary Brown; Djanybek Adyshev; Vytautus Bindokas; Jaideep Moitra; Joe G N Garcia; Steven M Dudek
Journal:  Microvasc Res       Date:  2010-01-04       Impact factor: 3.514

3.  Dynamin 2 and c-Abl are novel regulators of hyperoxia-mediated NADPH oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endothelium.

Authors:  Patrick A Singleton; Srikanth Pendyala; Irina A Gorshkova; Nurbek Mambetsariev; Jaideep Moitra; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

Review 4.  Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins.

Authors:  Srikanth Pendyala; Peter V Usatyuk; Irina A Gorshkova; Joe G N Garcia; Viswanathan Natarajan
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

Review 5.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.

Authors:  Randall S Frey; Masuko Ushio-Fukai; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

Review 6.  Cytoskeleton-membrane interactions in membrane raft structure.

Authors:  Gurunadh R Chichili; William Rodgers
Journal:  Cell Mol Life Sci       Date:  2009-04-16       Impact factor: 9.261

Review 7.  Non-muscle myosin II takes centre stage in cell adhesion and migration.

Authors:  Miguel Vicente-Manzanares; Xuefei Ma; Robert S Adelstein; Alan Rick Horwitz
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

8.  Phospholipase D-mediated activation of IQGAP1 through Rac1 regulates hyperoxia-induced p47phox translocation and reactive oxygen species generation in lung endothelial cells.

Authors:  Peter V Usatyuk; Irina A Gorshkova; Donghong He; Yutong Zhao; Satish K Kalari; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

Review 9.  Lipid rafts and caveolae and their role in compartmentation of redox signaling.

Authors:  Hemal H Patel; Paul A Insel
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

Review 10.  NOX enzymes and pulmonary disease.

Authors:  Brian Griffith; Srikanth Pendyala; Louise Hecker; Patty J Lee; Viswanathan Natarajan; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

View more
  26 in total

Review 1.  Redox regulation of vascular remodeling.

Authors:  Keyvan Karimi Galougahi; Euan A Ashley; Ziad A Ali
Journal:  Cell Mol Life Sci       Date:  2015-10-20       Impact factor: 9.261

Review 2.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

3.  Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.

Authors:  Long Shuang Huang; Panfeng Fu; Priya Patel; Anantha Harijith; Tianjiao Sun; Yutong Zhao; Joe G N Garcia; Jerold Chun; Viswanathan Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

4.  Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells.

Authors:  Peter V Usatyuk; Panfeng Fu; Vijay Mohan; Yulia Epshtein; Jeffrey R Jacobson; Julian Gomez-Cambronero; Kishore K Wary; Vytas Bindokas; Steven M Dudek; Ravi Salgia; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

5.  Inhibition of myosin light chain kinase reduces NADPH oxidase-mediated oxidative injury in rat brain following cerebral ischemia/reperfusion.

Authors:  Hong-Feng Zhang; Ting-Bo Li; Bin Liu; Zheng Lou; Jie-Jie Zhang; Jing-Jie Peng; Xiao-Jie Zhang; Qi-Lin Ma; Jun Peng; Xiu-Ju Luo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-04-29       Impact factor: 3.000

6.  Integration of TRPC6 and NADPH oxidase activation in lysophosphatidylcholine-induced TRPC5 externalization.

Authors:  Pinaki Chaudhuri; Michael A Rosenbaum; Lutz Birnbaumer; Linda M Graham
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-23       Impact factor: 4.249

7.  Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling.

Authors:  D Y Kim; D M Helfman
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

Review 8.  NADPH oxidases in lung health and disease.

Authors:  Karen Bernard; Louise Hecker; Tracy R Luckhardt; Guangjie Cheng; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

9.  MicroRNA regulation of nonmuscle myosin light chain kinase expression in human lung endothelium.

Authors:  Djanybek M Adyshev; Nurgul Moldobaeva; Brandon Mapes; Venkate Elangovan; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

10.  Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium.

Authors:  Anantha Harijith; Srikanth Pendyala; David L Ebenezer; Alison W Ha; Panfeng Fu; Yue-Ting Wang; Ke Ma; Peter T Toth; Evgeny V Berdyshev; Prasad Kanteti; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.